Filter
719
Text search:
candidates
Featured
Recommendations
66
New Publications
174
Language
Document type
No document type
366
Studies & Reports
141
Guidelines
86
Fact sheets
34
Manuals
32
Strategic & Response Plan
25
Resource Platforms
12
Training Material
9
Videos
6
Situation Updates
4
Online Courses
3
Brochures
1
Countries / Regions
India
45
Global
29
Liberia
18
South Africa
17
Nepal
16
Zambia
16
Kenya
14
Sierra Leone
12
Malawi
12
Western and Central Europe
12
Ethiopia
11
Latin America and the Carribbean
11
Africa
11
Nigeria
10
Tanzania
10
West and Central Africa
10
Myanmar / Burma
9
East and Southern Africa
9
Uganda
8
Bangladesh
8
Middle East and North Africa
8
Russia
8
Philippines
7
Syria
7
Rwanda
7
Ghana
6
Haiti
6
Germany
6
Eastern Europe
6
Guinea
5
Congo, Democratic Republic of
5
Zimbabwe
5
Cambodia
5
China
5
Namibia
5
Senegal
4
USA
4
South Sudan
4
Ukraine
4
Brazil
3
Botswana
3
Asia
3
Turkey
2
Thailand
2
Indonesia
2
Mozambique
2
Benin
2
Central African Republic
2
Peru
2
North Macedonia
2
Colombia
2
Madagascar
2
Lesotho
2
Georgia
2
Portugal
2
Burkina Faso
1
Morocco
1
Cameroon
1
Jordan
1
Afghanistan
1
Lebanon
1
Papua New Guinea
1
Argentina
1
Switzerland
1
Hungary
1
Mexico
1
Eastern Europe and Central Asia
1
Paraguay
1
Timor Leste/ East Timor
1
Tajikistan
1
Lithuania
1
Kyrgyzstan
1
Kazakhstan
1
Vietnam
1
Jamaica
1
France
1
United Kingdom
1
Norway
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
257
Clinical Guidelines
60
Public Health
29
Key Resources
26
Women & Child Health
21
Capacity Building
8
Pharmacy & Technologies
4
Annual Report MEDBOX
1
Toolboxes
COVID-19
111
TB
40
Mental Health
39
NTDs
35
Disability
33
HIV
27
Caregiver
27
Ebola & Marburg
25
AMR
16
Refugee
14
Rapid Response
12
Malaria
12
Conflict
9
Natural Hazards
9
Health Financing Toolbox
9
NCDs
8
Global Health Education
7
Planetary Health
7
Zika
6
Pharmacy
6
2.0 Rapid Response
5
Polio
4
Social Ethics
4
Cholera
3
Typhoon
3
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
Scientists and researchers managed to produce vaccines to protect against COVID-19. Vaccine candidates have recently been approved in some countries and are in the approval process in others, yet misinformation about the safety and effects of any fu
...
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac
...
COVID-19 vaccine tracker and landscape
recommended
The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline.
The COVID-19 vaccine tracker:
Provides summary tables of COVID-19 vaccine
...
This tracker, developed by the Vaccine Centre at the London School of Hygiene & Tropical Medicine, will follow COVID-19 vaccine candidates as they progress through the development pipeline. We will update it weekly. An overview of the different vac
...
BioDrugs. 2023 Sep 20;37(6):737–756. doi: 10.1007/s40259-023-00623-4
There are many malaria vaccine candidates in development, with more than a dozen of these in clinical development. RTS,S/AS01 (also known as Mosquirix) is the most advanced mal
...
Vacunas
recommended
COVID Reference 23 May 2021
Vaccines
recommended
COVID Reference 23 May 2021
This chronology of facts has challenged public health systems worldwide and regulatory bodies are no exception. Regulatory authorities with mechanisms in place to authorize the use of investigational products had to development guidelines and procedures, create task forces and alliances to maximize
...
24 September 2021. The vaccine has been authorized by the Chinese National Regulatory Authority (NRA) – the National Medicinal Product Administration (NMPA) – as well as other regulatory authorities. Because WHO has granted Emergency Use Listing (EUL) for the COVID-19 Vaccine BIBP/ Sinopharm, th
...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
7 June 2021
The Africa Regulatory Taskforce is a joint effort established by the Africa Centres for Disease Control and Prevention (Africa CDC), the African Union Development Agency (AUDA-NEPAD) coordinated African Medicines Regulatory Harmonization (AMRH) Initiative, and the World Health Organisat
...
24 September 2021. The vaccine has been authorized by the Chinese National Regulatory Authority (NRA) – the National Medicinal Product Administration (NMPA) – as well as other regulatory authorities. Because WHO has granted Emergency Use Listing (EUL) for the Sinovac COVID-19 vaccine (Vero Cell
...
10 December 2020
Many countries are using the approach of mixing vaccine doses from different manufacturers. What do we know about the safety and efficacy of this approach? What does the evidence tell us about using a fraction of the vaccine dose ? Dr Katherine O’Brien explains in Science in 5 this week.
Closed C
...
